FADYA SISO: Open Payments
NPI 1932854916 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,951 in 233 payments from 18 companies in 2025. Trend: 2023 $6,024 · 2024 $3,230 · 2025 $4,951
Food & beverage: $4,756Education: $195
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 63 | $1,165 |
| ABBVIE INC. | 54 | $1,078 |
| Janssen Biotech, Inc. | 36 | $945 |
| GENZYME CORPORATION | 10 | $414 |
| UCB, Inc. | 8 | $271 |
| Novartis Pharmaceuticals Corporation | 11 | $248 |
| E.R. Squibb & Sons, L.L.C. | 26 | $207 |
| GlaxoSmithKline, LLC. | 5 | $199 |
| Organon LLC | 4 | $64 |
| PFIZER INC. | 3 | $60 |
Products named: TREMFYA, RINVOQ, KRYSTEXXA, KEVZARA, SKYRIZI, OTEZLA, Bimzelx, ORENCIA.
Industry payments across MI — which companies pay providers there.
